Atlas Trials

Metformin Plus/Minus Fasting Mimicking Diet to Target the Metabolic Vulnerabilities of LKB1-inactive Lung Adenocarcinoma

Clinical trial NCT03709147 · UNKNOWN

Trial details

NCT number
NCT03709147
Sponsor
Marina Garassino
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced LKB1-inactive Lung Adenocarcinoma
Start date
2018-10-30
Primary completion
2023-09-10
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.